ISOLX | LIRIX | ISOLX / LIRIX | |
Total Expense Ratio | 0.40 | 0.14 | 286% |
Annual Report Gross Expense Ratio | 0.41 | 0.17 | 241% |
Fund Existence | 13 years | 14 years | - |
Gain YTD | 3.985 | 4.357 | 91% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 2000000 | 13% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 106M | 13.3B | 1% |
Annual Yield % from dividends | 2.29 | 2.82 | 81% |
Returns for 1 year | 6.85 | 7.28 | 94% |
Returns for 3 years | 21.99 | 24.82 | 89% |
Returns for 5 years | 11.99 | 22.96 | 52% |
Returns for 10 years | 28.46 | 53.81 | 53% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ASCGX | 19.32 | 0.15 | +0.78% |
Lisanti Small Cap Growth | |||
TVOCX | 34.05 | 0.11 | +0.32% |
Touchstone Small Cap Value C | |||
RTOUX | 39.09 | 0.12 | +0.31% |
Russell Inv Tax-Managed US Mid&Sm Cap M | |||
SHSSX | 65.31 | -0.08 | -0.12% |
BlackRock Health Sciences Opps Instl | |||
ANVHX | 9.83 | -0.02 | -0.20% |
American Century Non-US Intrs Val I |